Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Atypical presentation of Kaposi sarcoma in an HIV-negative patient: a case report and comprehensive literature review.
Ann Med Surg (Lond)
December 2024
Faculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Introduction: Kaposi's sarcoma (KS) is a systemic disease that is marked by the presence of neoplastic lesions caused by human herpesvirus-8 (HHV-8) infections. KS usually impacts people with weakened immune systems, although there have been a few cases of it occurring in individuals with normal immune function. Medical records and histopathological slides of the case were retrospectively reviewed.
View Article and Find Full Text PDFThe association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a prospective cohort study.
Lancet Glob Health
December 2024
Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. Electronic address:
Background: Breast cancer is the most common malignancy diagnosed among women in South Africa, with the aggressive triple-negative subtype comprising approximately 15% of breast cancers in this population. South Africa has the largest population of people with HIV in the world. This study aims to evaluate the association between HIV status and the proportion of patients with breast cancer with the triple-negative subtype.
View Article and Find Full Text PDFLearning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.
J Int AIDS Soc
November 2024
Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Introduction: Perspectives on long-acting injectable cabotegravir/rilpivirine (CAB/RPV-LA) from HIV health disparity populations are under-represented in current literature yet crucial to optimize delivery.
Methods: Between August 2022 and May 2023, we conducted in-depth interviews with people with HIV (PWH) at four HIV clinics in Atlanta, Chicago and San Francisco. Eligibility criteria were current CAB/RPV-LA use with receipt of ≥3 injections or CAB/RPV-LA discontinuation.
Negative Treponemal Serologies in Syphilitic Panuveitis.
JAMA Ophthalmol
November 2024
Southeastern Retina Associates, Chattanooga, Tennessee.
Reported impact of creativity in the Wakakosha ('You're Worth It') internal stigma intervention for young people living with HIV in Harare, Zimbabwe.
PLOS Glob Public Health
November 2024
Centre for Positive Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Internal stigma (negative judgements towards oneself) continues to be a barrier to HIV treatment, management and care, and has global public health consequences. People living with HIV (PLHIV) who report internal stigma are less likely to seek care, adhere to treatment and can experience increased depression and lower quality of life. The Wakakosha ('You're Worth It') programme sought to reduce internal stigma among young PLHIV using inquiry-based stress reduction (IBSR), a cognitive and awareness-based methodology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!